Basit öğe kaydını göster

dc.contributor.authorALTINBAŞ, Akif
dc.date.accessioned2020-08-07T12:51:29Z
dc.date.available2020-08-07T12:51:29Z
dc.date.issued2019
dc.identifier10.1007/s00198-018-4736-x
dc.identifier.issn0937941X (ISSN)
dc.identifier.urihttp://hdl.handle.net/20.500.12498/2801
dc.description.abstractI have read Treister-Goltzman Y’s article with a great interest since I have been working on the answer whether physicians have to treat the patients with isolated lactase enzyme deficiency [1]. By isolated lactase enzyme deficiency, I would rather refer to the patients with lactase deficiency determined by objective diagnostic tools, e.g., genetic analyses, direct enzyme activity measurement through intestinal biopsy or H2 breath test, whereas presenting no lactose intolerance related symptoms [2, 3]. Most of these patients are diagnosed during the lactose intolerance evaluation due to the family history.
dc.language.isoEnglish
dc.publisherSpringer London
dc.sourceOsteoporosis International
dc.titleOsteoporosis risk of the subjects with isolated lactase enzyme deficiency
dc.typeEditöre Mektup


Bu öğenin dosyaları:

Thumbnail

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster